Design
Review
Authors
Loading...
May guide RAS inhibitor use in glomerular disease; leaves open intrarenal-specific therapeutic targets.
Key points are not available for this paper at this time.
L. Gabriel Navar (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: